Anika Therapeutics, Inc. (ANIK) Stock Overview
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Anika Therapeutics, Inc.
Anika Therapeutics, Inc., a joint preservation company, focuses on early intervention orthopedics in the United States, Europe, and internationally. The company offers osteoarthritis (OA) pain management products and services, such as Monovisc and Orthovisc, which are single- and…
Source: Yahoo Finance
Sector & Industry
Anika Therapeutics, Inc. operates in the Healthcare sector, within the Drug Manufacturers - Specialty & Generic industry group. It is listed on the NASDAQ exchange.
Anika Therapeutics, Inc. at a Glance
| Company | Anika Therapeutics, Inc. |
| Ticker | ANIK |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $20.81 |
| Market cap | $278.50M |
| P/E ratio (trailing) | — |
| EPS (trailing) | -$0.23 |
| 52-week high | $22.88 |
| 52-week low | $8.37 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 0.20 |
| Return on equity (ROE) | -2.19% |
| Debt-to-equity | 18.39% |
| Average volume | 96,836 |
| Shares outstanding | 13.38M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Employees | 235 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Frequently Asked Questions
- What is Anika Therapeutics, Inc.'s current P/E ratio?
- Anika Therapeutics, Inc. (ANIK) has a trailing P/E ratio of — as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Anika Therapeutics, Inc.'s market capitalisation?
- Anika Therapeutics, Inc.'s market cap is $278.50M based on our latest snapshot. See how it ranks by market cap →
- What is ANIK's 52-week range?
- Over the past 52 weeks, ANIK has traded between $8.37 and $22.88. What does the 52-week range mean? →
- How volatile is Anika Therapeutics, Inc. compared to the market?
- Anika Therapeutics, Inc. has a beta of 0.20, meaning it has historically moved less than the broader market. What does beta measure? →
- Does Anika Therapeutics, Inc. pay a dividend?
- Anika Therapeutics, Inc. does not currently pay a dividend according to our latest data.
- What exchange is ANIK listed on?
- ANIK is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is Anika Therapeutics, Inc. in?
- Anika Therapeutics, Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
Need to convert currencies or units alongside this data? Our quick conversion tools are always on hand.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →